Hikal Ltd (HIKAL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 175814, "name": "Hikal", "stock_name": "Hikal", "full_name": "Hikal Ltd", "name_url": "stocks-analysis/hikal", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "178.60", "chg": 0.6, "chgp": "0.34%", "dir": 1, "prev_price": "178.00", "mcapval": "2,202.15 Cr", "mcap": "Small Cap", "scripcode": 524735, "symbol": "HIKAL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE475B01022", "curr_date": "Jun 11, 11:02 AM", "curr_time": "11:04 AM", "last_traded_at": "Jun 11, 11:02 AM IST", "bse_nse_vol": "33.59 k", "exc_status": "Active", "traded_date": "Jun 11, 2026", "traded_date_str": "2026 06 11", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hikal-175814-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Hikal Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Market Underperformance", "link": "https://www.marketsmojo.com/news/stock-recommendation/hikal-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-market-underperformance-4040456", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HikalLtd_mojoScore_4040456.png", "date": "2026-06-09 08:36:09", "description": "Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 8 June 2026. This revision reflects deteriorating fundamentals, subdued financial trends, and weak technical signals despite some positive quarterly results. The company’s Mojo Score has declined to 29.0, underscoring growing concerns among institutional investors and market analysts alike." }, { "title": "Hikal Ltd Declines 4.24% Despite Quarterly Profit Surge: Key Market Moves This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-declines-424-despite-quarterly-profit-surge-key-market-moves-this-week-4024617", "imagepath": "", "date": "2026-05-31 14:00:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock surges 4.22% on strong volume</p>\n <p><strong>27 May:</strong> Quarterly results reveal profit recovery but operational challenges</p>\n <p><strong>29 May:</strong> Intraday low amid heavy price pressure; stock closes sharply lower</p>\n <p><strong>29 May:</strong> Strong quarterly turnaround reported alongside mixed long-term returns</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.205.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close<..." }, { "title": "Hikal Ltd Hits Intraday Low Amid Price Pressure on 29 May 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-hits-intraday-low-amid-price-pressure-on-29-may-2026-4019721", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HikalLtd_priceRelatedfactors_4019721.png", "date": "2026-05-29 10:01:21", "description": "Hikal Ltd experienced a notable decline today, touching an intraday low of Rs 201.25, reflecting significant price pressure and heightened volatility. The stock underperformed its sector and broader market indices, reversing gains from the previous three sessions." }, { "title": "Hikal Ltd Reports Strong Quarterly Turnaround Amid Mixed Long-Term Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-reports-strong-quarterly-turnaround-amid-mixed-long-term-returns-4019082", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HikalLtd_fintrenddot_4019082.png", "date": "2026-05-29 08:00:07", "description": "Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to positive, driven by exceptional growth in profitability metrics, despite some lingering challenges in longer-term returns and capital efficiency." }, { "title": "Are Hikal Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-hikal-ltd-latest-results-good-or-bad-4018957", "imagepath": "", "date": "2026-05-28 19:23:42", "description": "Hikal Ltd's latest financial results for Q4 FY26 present a mixed operational picture. The company reported net sales of ₹519.40 crores, reflecting a quarter-on-quarter growth of 5.08% from ₹494.30 crores in Q3 FY26. However, this represents a year-on-year decline of 5.97% compared to ₹552.40 crores in Q4 FY25, indicating ongoing challenges in key markets, particularly in the crop protection segment.\n\nThe net profit for the quarter was ₹14.40 crores, a significant recovery from a loss of ₹5.90 crores in the previous quarter, primarily driven by improved operational performance and a favorable tax adjustment. Nonetheless, the year-on-year comparison shows a substantial decline of 71.31% from ₹50.20 crores in Q4 FY25, highlighting a concerning erosion in earnings power.\n\nOperating margins improved to 20.39% from 16.85% in the previous quarter, yet this is still 204 basis points lower than the 22.44% margin ach..." }, { "title": "Hikal Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/hikal-ltd-is-rated-sell-by-marketsmojo-4017921", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HikalLtd_mojoScore_4017921.png", "date": "2026-05-28 10:10:30", "description": "Hikal Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Hikal Q4 FY26: Profit Recovery Masks Deeper Operational Struggles", "link": "https://www.marketsmojo.com/news/result-analysis/hikal-q4-fy26-profit-recovery-masks-deeper-operational-struggles-4017650", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/Hikal_quaterlyResult_4017650.png", "date": "2026-05-27 22:00:43", "description": "Hikal Ltd., a Mumbai-based pharmaceutical and specialty chemicals manufacturer, reported a net profit of ₹14.40 crores for Q4 FY26 (January-March 2026), a dramatic reversal from the ₹5.90 crore loss recorded in the previous quarter. However, the year-on-year comparison reveals a concerning 71.31% decline from the ₹50.20 crore profit posted in Q4 FY25, underscoring persistent operational headwinds that continue to weigh on the company's performance." }, { "title": "When is the next results date for Hikal Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hikal-ltd-4003828", "imagepath": "", "date": "2026-05-21 23:18:21", "description": "The next results date for Hikal Ltd is scheduled for 27 May 2026...." }, { "title": "Hikal Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/hikal-ltd-is-rated-strong-sell-3995258", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HikalLtd_mojoScore_3995258.png", "date": "2026-05-17 10:10:37", "description": "Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 439, "sid": "175814", "stock_news_url": "https://www.marketsmojo.com/news/hikal-175814" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "05-Jun-2026", "details": "Intimation of Newspaper Publication of Postal Ballot Notice and remote e- Voting", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot", "datetime": "04-Jun-2026", "details": "Intimation of Postal Ballot notice and remote e-Voting", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "03-Jun-2026", "details": "Announcement under Regulation 30 (LODR)- Transcript of Earnings Call held on May 27 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Hikal Ltd has declared <strong>10%</strong> dividend, ex-date: 17 Feb 26", "dt": "2026-02-17", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Hikal Ltd has announced <strong>2:10</strong> stock split, ex-date: 27 Feb 15", "dt": "2015-02-27", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Hikal Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 18", "dt": "2018-06-22", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Stock surges 4.22% on strong volume

27 May: Quarterly results reveal profit recovery but operational challenges

29 May: Intraday low amid heavy price pressure; stock closes sharply lower

29 May: Strong quarterly turnaround reported alongside mixed long-term returns

Week Open

Rs.205.00

Week Close<...

Read full news article

Hikal Ltd Hits Intraday Low Amid Price Pressure on 29 May 2026

2026-05-29 10:01:21

Hikal Ltd experienced a notable decline today, touching an intraday low of Rs 201.25, reflecting significant price pressure and heightened volatility. The stock underperformed its sector and broader market indices, reversing gains from the previous three sessions.

Read full news article

Hikal Ltd Reports Strong Quarterly Turnaround Amid Mixed Long-Term Returns

2026-05-29 08:00:07

Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026. The company’s financial trend has shifted from flat to positive, driven by exceptional growth in profitability metrics, despite some lingering challenges in longer-term returns and capital efficiency.

Read full news article

Are Hikal Ltd latest results good or bad?

2026-05-28 19:23:42

Hikal Ltd's latest financial results for Q4 FY26 present a mixed operational picture. The company reported net sales of ₹519.40 crores, reflecting a quarter-on-quarter growth of 5.08% from ₹494.30 crores in Q3 FY26. However, this represents a year-on-year decline of 5.97% compared to ₹552.40 crores in Q4 FY25, indicating ongoing challenges in key markets, particularly in the crop protection segment. The net profit for the quarter was ₹14.40 crores, a significant recovery from a loss of ₹5.90 crores in the previous quarter, primarily driven by improved operational performance and a favorable tax adjustment. Nonetheless, the year-on-year comparison shows a substantial decline of 71.31% from ₹50.20 crores in Q4 FY25, highlighting a concerning erosion in earnings power. Operating margins improved to 20.39% from 16.85% in the previous quarter, yet this is still 204 basis points lower than the 22.44% margin ach...

Read full news article

Hikal Ltd is Rated Sell by MarketsMOJO

2026-05-28 10:10:30

Hikal Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Hikal Q4 FY26: Profit Recovery Masks Deeper Operational Struggles

2026-05-27 22:00:43

Hikal Ltd., a Mumbai-based pharmaceutical and specialty chemicals manufacturer, reported a net profit of ₹14.40 crores for Q4 FY26 (January-March 2026), a dramatic reversal from the ₹5.90 crore loss recorded in the previous quarter. However, the year-on-year comparison reveals a concerning 71.31% decline from the ₹50.20 crore profit posted in Q4 FY25, underscoring persistent operational headwinds that continue to weigh on the company's performance.

Read full news article

When is the next results date for Hikal Ltd?

2026-05-21 23:18:21

The next results date for Hikal Ltd is scheduled for 27 May 2026....

Read full news article

Hikal Ltd is Rated Strong Sell

2026-05-17 10:10:37

Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article